Sign-Up for News
    -Click Here-

Multiple Sclerosis (MS) Treatment Options_Updated May 2017

Reset Font Size

The following U.S. Food and Drug Administration (FDA)-approved disease-modifying agents (.pdf brochure) reduce disease activity and disease progression for many people with relapsing forms of MS, including relapsing-remitting MS, as well as progressive forms of MS in those people who experience relapses. 

Medications are used in multiple sclerosis (MS) to modify the disease course, treat relapses — also called attacks or exacerbations — and manage symptoms. Along with the other essential components of comprehensive MS care, these medications help people manage their MS and enhance their comfort and quality of life. 

 

Following the treatment plan that you and your doctor have established is the best possible strategy for managing your MS:

  • Early and ongoing treatment with disease-modifying therapy is supported by the MS Coalition which includes the National MS Society. This evidence-based Consensus on Disease-Modifying Therapies (.pdf) and Summary (.pdf) may be useful when discussing treatment options with your healthcare provider and advocating with insurers for access and coverage. This paper was last updated in 2016. 
  • Adhering to your disease-modifying medication is a key element of treatment effectiveness.
  • For help in managing the costs of these medications, read about the patient assistance programs offered by the pharmaceutical companies.
  • READ MORE directly from the Source of this aerticle, the National Multiple Sclerosis Society
  • ...........

 

 

top